Table 1.
Drug Effect on Fiber Volley |
||||
---|---|---|---|---|
n | Amplitude | Area | Latency | |
Furosemide (2.5 mM, 30 min) | 9 | 79 ± 6%** | 84 ± 6%* | 110 ± 2%** |
Furosemide (2.5 mM, 30 min) with gabazine | 6 | 81 ± 4%** | 84 ± 4%* | 109 ± 2%* |
Bumetanide (20 µM, 30 min) | 7 | 96 ± 2% | 98 ± 4% | 100 ± 2% |
VU0240551(20 µM, 30 min) | 5 | 108 ± 6% | 99 ± 2% | 98 ± 2% |
DIDS (0.5 mM, 45 min) | 9 | 80 ± 5%** | 90 ± 6% | 113 ± 3%** |
DIDS + furosemide (45 min) | 5 | 55 ± 6%* | 74 ± 7%* | 124 ± 2%** |
S0859 (30 µM, 45 min) | 7 | 102 ± 1% | 102 ± 5% | 101 ± 2% |
Sucrose (30 mM, 30 min) | 6 | 89 ± 4% | 93 ± 4% | 97 ± 1%* |
ZD7288 (20 µM, 30 min) | 11 | 100 ± 4% | 101 ± 4% | 101 ± 2% |
Furosemide (2.5 mM, 30 min) with ZD7288 | 7 | 76 ± 4%** | 83 ± 5%* | 113 ± 2%** |
Alveus, furosemide (2.5 mM, 30 min) | 11 | 66 ± 4%** | 74 ± 4%** | 128 ± 3%** |
Alveus, bumetanide (20–50 µM, 30 min) | 9 | 100 ± 1% | 103 ± 4% | 103 ± 1%** |
Percentages (means ± SE) are relative to control before drug application. All data were collected in the presence of CNQX (20–40 µM), MK 801 (10 µM), and CGP55845 (2 µM).
P < 0.05;
P < 0.01.